Literature DB >> 12643623

Elimination of local macrophages in intestine prevents chronic colitis in interleukin-10-deficient mice.

Norihiko Watanabe1, Koichi Ikuta, Kazuichi Okazaki, Hiroshi Nakase, Yasuhiko Tabata, Minoru Matsuura, Hiroyuki Tamaki, Chiharu Kawanami, Tasuku Honjo, Tsutomu Chiba.   

Abstract

Uncontrolled activation of T cells and macrophages is involved in the development of inflammatory bowel disease (IBD). However, the precise role of intestinal macrophages for development of IBD is till unclear. To investigate the role of local macrophages for development of IBD, we developed poly-D, L-lactic acid microspheres containing dichloromethylene diphosphonate, which was specifically taken up by macrophages and depleted them, and then the animal model for human IBD was treated with this reagent. We have shown that rectal administration of the microspheres reduced the numbers of resident macrophages in the intestinal lymphoid follicles of interleukin-10-deficient mice. Importantly, depletion of intestinal macrophages was associated with suppression of development of chronic colitis. These results suggest that local macrophages in the intestine play a critical role in the development of chronic colitis in an animal model for IBD. Our study implies that elimination of resident macrophages in the intestine may become a therapeutic approach to IBD.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12643623     DOI: 10.1023/a:1021960401290

Source DB:  PubMed          Journal:  Dig Dis Sci        ISSN: 0163-2116            Impact factor:   3.199


  38 in total

1.  The Toll-like receptor 2 is recruited to macrophage phagosomes and discriminates between pathogens.

Authors:  D M Underhill; A Ozinsky; A M Hajjar; A Stevens; C B Wilson; M Bassetti; A Aderem
Journal:  Nature       Date:  1999-10-21       Impact factor: 49.962

Review 2.  Alterations of the immune system in ulcerative colitis and Crohn's disease.

Authors:  R P MacDermott; W F Stenson
Journal:  Adv Immunol       Date:  1988       Impact factor: 3.543

3.  Anti-interleukin 12 treatment regulates apoptosis of Th1 T cells in experimental colitis in mice.

Authors:  I J Fuss; T Marth; M F Neurath; G R Pearlstein; A Jain; W Strober
Journal:  Gastroenterology       Date:  1999-11       Impact factor: 22.682

4.  A frameshift mutation in NOD2 associated with susceptibility to Crohn's disease.

Authors:  Y Ogura; D K Bonen; N Inohara; D L Nicolae; F F Chen; R Ramos; H Britton; T Moran; R Karaliuskas; R H Duerr; J P Achkar; S R Brant; T M Bayless; B S Kirschner; S B Hanauer; G Nuñez; J H Cho
Journal:  Nature       Date:  2001-05-31       Impact factor: 49.962

5.  Interleukin-10-deficient mice develop chronic enterocolitis.

Authors:  R Kühn; J Löhler; D Rennick; K Rajewsky; W Müller
Journal:  Cell       Date:  1993-10-22       Impact factor: 41.582

6.  Liposome-encapsulated dichloromethylene diphosphonate induces macrophage apoptosis in vivo and in vitro.

Authors:  M Naito; H Nagai; S Kawano; H Umezu; H Zhu; H Moriyama; T Yamamoto; H Takatsuka; Y Takei
Journal:  J Leukoc Biol       Date:  1996-09       Impact factor: 4.962

7.  IL-12, but not IFN-gamma, plays a major role in sustaining the chronic phase of colitis in IL-10-deficient mice.

Authors:  N J Davidson; S A Hudak; R E Lesley; S Menon; M W Leach; D M Rennick
Journal:  J Immunol       Date:  1998-09-15       Impact factor: 5.422

8.  Macrophage phagocytosis of biodegradable microspheres composed of L-lactic acid/glycolic acid homo- and copolymers.

Authors:  Y Tabata; Y Ikada
Journal:  J Biomed Mater Res       Date:  1988-10

9.  The role of macrophages in T cell-mediated autoimmune diabetes in nonobese diabetic mice.

Authors:  H S Jun; C S Yoon; L Zbytnuik; N van Rooijen; J W Yoon
Journal:  J Exp Med       Date:  1999-01-18       Impact factor: 14.307

10.  Production of natural killer cell stimulatory factor (interleukin 12) by peripheral blood mononuclear cells.

Authors:  A D'Andrea; M Rengaraju; N M Valiante; J Chehimi; M Kubin; M Aste; S H Chan; M Kobayashi; D Young; E Nickbarg
Journal:  J Exp Med       Date:  1992-11-01       Impact factor: 14.307

View more
  39 in total

Review 1.  Irritable bowel syndrome: methods, mechanisms, and pathophysiology. Neural and neuro-immune mechanisms of visceral hypersensitivity in irritable bowel syndrome.

Authors:  Bin Feng; Jun Ho La; Erica S Schwartz; G F Gebhart
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2012-03-08       Impact factor: 4.052

2.  Preventive and therapeutic effects of tacrolimus in an interleukin-10-deficient mouse model of colitis.

Authors:  Yohei Okada; Noriaki Maeda; Shoji Takakura; Keiji Miyata; Masahiro Koshiba
Journal:  Inflamm Res       Date:  2011-08-10       Impact factor: 4.575

Review 3.  Securing the immune tightrope: mononuclear phagocytes in the intestinal lamina propria.

Authors:  Chen Varol; Ehud Zigmond; Steffen Jung
Journal:  Nat Rev Immunol       Date:  2010-06       Impact factor: 53.106

Review 4.  Intestinal dendritic cells in the pathogenesis of inflammatory bowel disease.

Authors:  Sergio Rutella; Franco Locatelli
Journal:  World J Gastroenterol       Date:  2011-09-07       Impact factor: 5.742

5.  Role of TNFR-related 2 mediated immune responses in dextran sulfate sodium-induced inflammatory bowel disease.

Authors:  Woon-Ki Kim; Jin-Soo Park; Ok-Ju Sul; Jae-Hee Seo; Byum-Kyu Choi; Hee-Young Park; Anne M Latour; Beverly H Koller; Byoung S Kwon; Choon-Soo Jeong
Journal:  Mol Cells       Date:  2011-01-06       Impact factor: 5.034

6.  Systemic macrophage depletion inhibits Helicobacter bilis-induced proinflammatory cytokine-mediated typhlocolitis and impairs bacterial colonization dynamics in a BALB/c Rag2-/- mouse model of inflammatory bowel disease.

Authors:  Sureshkumar Muthupalani; Zhongming Ge; Yan Feng; Barry Rickman; Melissa Mobley; Amanda McCabe; Nico Van Rooijen; James G Fox
Journal:  Infect Immun       Date:  2012-10-01       Impact factor: 3.441

7.  Paired immunoglobulin-like receptor B (PIR-B) negatively regulates macrophage activation in experimental colitis.

Authors:  Ariel Munitz; Eric T Cole; Amanda Beichler; Katherine Groschwitz; Richard Ahrens; Kris Steinbrecher; Tara Willson; Xiaonan Han; Lee Denson; Marc E Rothenberg; Simon P Hogan
Journal:  Gastroenterology       Date:  2010-04-14       Impact factor: 22.682

Review 8.  Influence of host immunoregulatory genes, ER stress and gut microbiota on the shared pathogenesis of inflammatory bowel disease and Type 1 diabetes.

Authors:  Altin Gjymishka; Roxana M Coman; Todd M Brusko; Sarah C Glover
Journal:  Immunotherapy       Date:  2013-12       Impact factor: 4.196

9.  A novel Toll-like receptor 4 antagonist antibody ameliorates inflammation but impairs mucosal healing in murine colitis.

Authors:  Ryan Ungaro; Masayuki Fukata; David Hsu; Yasmin Hernandez; Keith Breglio; Anli Chen; Ruliang Xu; John Sotolongo; Cecillia Espana; Julia Zaias; Greg Elson; Lloyd Mayer; Marie Kosco-Vilbois; Maria T Abreu
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2009-04-09       Impact factor: 4.052

10.  Current understanding of the role of PPARγ in gastrointestinal cancers.

Authors:  Bing Zou; Liang Qiao; Benjamin C Y Wong
Journal:  PPAR Res       Date:  2009-10-26       Impact factor: 4.964

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.